Skip to main content
Watch Insiders
INBX filings

Corporate insider profile

Douglas Forsyth Filing Activity

Latest reported as Corporate insider of Inhibrx Biosciences, Inc. (INBX).

Purchase filings
1
Reported companies
1
Net open-market value
$286,617
Latest transaction
Sep 8, 2026

Affiliated corporations

Reported company relationships

INBXLatest reported

Inhibrx Biosciences, Inc.

Corporate insider

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 8, 2026Inhibrx Biosciences, Inc. (INBX)Corporate insiderOpen Market Purchase2,500$114.65$286,617